If you need patent protection in more than one or two countries, the Patent Cooperation Treaty is almost certainly the route you should take. The PCT does not grant patents -- no international treaty does -- but it provides a unified filing and preliminary examination procedure that delays the enormous cost of national prosecution while giving you an expert assessment of your invention's patentability. Over 270,000 international applications are filed under the PCT each year, and for good reason: it buys you time, information, and strategic flexibility that direct national filing cannot match.
This chapter covers the PCT system end to end -- what it is, how it works, what it costs, and how to use it strategically.
What the PCT Is and Is Not
The Patent Cooperation Treaty is an international treaty administered by WIPO (the World Intellectual Property Organization) with 158 contracting states. It was signed in 1970, entered into force in 1978, and has been amended multiple times since. Its purpose is to simplify the process of seeking patent protection in multiple countries.
The PCT creates a single international filing procedure. You file one application, in one language, at one patent office (called a "receiving office"), and that single filing has the legal effect of a national application in all 158 contracting states simultaneously. From that single filing, you receive an international search report and a written opinion on patentability before you ever need to commit to specific countries.
The PCT does not grant patents. This is the single most important thing to understand about the system. No matter how favorable your international search report or preliminary examination report, you do not have a patent until a national or regional patent office grants one. The PCT is a filing and preliminary assessment system, not a grant system. Patents are always granted by national or regional offices -- the USPTO, EPO, CNIPA, JPO, and others -- during what is called the "national phase."
What You Get from the PCT
| PCT Feature | What It Provides | What It Does Not Provide |
|---|---|---|
| Single international filing | Legal effect of a national filing in all 158 contracting states | A granted patent in any country |
| International search report (ISR) | Expert prior art search and citation analysis | A binding determination of patentability |
| Written opinion / IPRP | Preliminary, non-binding assessment of novelty, inventive step, and industrial applicability | A final examination result |
| 18-month publication on PATENTSCOPE | Global disclosure and prior art effect | Enforceable patent rights |
| 30-month deadline for national phase entry | Time to evaluate markets and decide where to pursue patents | Automatic patent protection without further action |
The PCT Lifecycle
The PCT procedure follows a defined sequence of phases, each with specific deadlines calculated from the "priority date" -- typically the filing date of your earliest national application from which you claim priority.
The complete PCT lifecycle from priority filing through national phase entry and grant. Each stage has specific deadlines calculated from the priority date.
Key Milestones and Deadlines
| Milestone | Deadline (from Priority Date) | What Happens |
|---|---|---|
| PCT application filed | 12 months | Must claim priority to earlier national filing within this window |
| International search report (ISR) issued | ~16 months (or 3 months from receipt by ISA, whichever is later) | ISA delivers search report and written opinion to applicant |
| International publication | 18 months | Application published on WIPO PATENTSCOPE; becomes prior art |
| Article 19 amendments | 2 months after ISR transmittal (or 16 months from priority, whichever expires later) | Applicant may amend claims based on ISR |
| Demand for Chapter II examination | 22 months (or 3 months from ISR transmittal, whichever is later) | Optional: request international preliminary examination |
| National phase entry deadline | 30 months (31 months for some offices) | Fatal deadline: failure to enter means loss of rights in that country |
PCT vs. Paris Convention Direct Filing
Before the PCT existed, the only way to file in multiple countries was through the Paris Convention route: file a national application, then file separate applications directly in each country within 12 months. The Paris Convention is still available, and in some situations it is the better choice.
| Factor | Paris Convention (Direct Filing) | PCT Route |
|---|---|---|
| Time to enter national offices | 12 months from priority date | 30 months from priority date |
| Upfront cost | High: full national fees, translations, and agent fees due at 12 months | Low: single international filing fee, search fee, and transmittal fee |
| When major costs hit | 12 months | 30 months |
| Prior art feedback before national filing | None (unless you commission a private search) | ISR and written opinion provided at ~16 months |
| Number of filings to manage | One per country | One international filing, then national entries at 30 months |
| Best for | 1-2 countries, speed to grant is critical, no uncertainty about target markets | 3+ countries, need time to assess commercial viability, want expert search feedback |
When direct filing beats the PCT. If you only need protection in one or two countries and you already know which ones, direct filing under the Paris Convention is faster and can be cheaper overall. The PCT adds value when you need time to decide, when you are targeting many jurisdictions, or when you want an authoritative prior art search before committing to national prosecution costs. If speed to grant is your priority -- for example, in a fast-moving competitive landscape -- direct filing combined with accelerated examination programs (Track One at the USPTO, PACE at the EPO) may get you to grant faster than the PCT route.
Cost Comparison: 5-Country Filing
To illustrate the cost difference, consider a hypothetical applicant filing in the United States, Europe (via EPO), Japan, South Korea, and China.
| Cost Component | Paris Convention (Direct) | PCT Route |
|---|---|---|
| Filing fees (5 offices) at 12 months | ~$8,000-12,000 | Deferred to 30 months |
| Translations at 12 months | ~$15,000-25,000 | Deferred to 30 months |
| Local agent fees at 12 months | ~$5,000-10,000 | Deferred to 30 months |
| PCT international filing fee | N/A | ~$1,500 (1,330 CHF base) |
| PCT search fee | N/A | ~$600-2,200 (varies by ISA) |
| PCT transmittal fee | N/A | ~$100-300 (varies by receiving office) |
| Total at 12 months | $28,000-47,000 | $2,200-4,000 |
| Total at 30 months (national phase) | Same total as above | $28,000-47,000 (national phase costs) plus PCT fees already paid |
The PCT does not eliminate national phase costs -- it defers them by 18 months. Those 18 months let you raise capital, assess market demand, refine your claims based on the ISR, and decide whether to proceed in all five countries or drop some. If you abandon the application before national phase, you have saved tens of thousands of dollars compared to the Paris route.
Filing a PCT Application
Who Can File
Any national or resident of a PCT contracting state can file a PCT application. If multiple applicants are named, only one needs to meet this requirement. The PCT covers 158 states, including all major industrial nations. Notable non-members include a small number of developing countries, though coverage is nearly universal.
Where to File (Receiving Office)
You file your PCT application with a "receiving office" (RO). This is typically your national patent office -- a U.S. applicant files with the USPTO as receiving office, a Japanese applicant files with the JPO, and so on. Applicants from any contracting state can also file directly with the International Bureau of WIPO (RO/IB) in Geneva.
Some countries require national security clearance before filing with an office other than your home office. U.S. applicants, for example, generally need a foreign filing license from the USPTO before filing directly with WIPO or a foreign receiving office.
Required Elements
A PCT application must contain:
- A request -- the PCT request form (Form PCT/RO/101) containing bibliographic data about the applicant, inventor, priority claims, and ISA selection.
- A description -- the written disclosure of the invention, following the same requirements as a national application (enablement, written description).
- Claims -- one or more claims defining the scope of protection sought.
- Drawings -- where required by the nature of the invention.
- An abstract -- a summary of the invention for search and classification purposes.
Language Rules
You can file in any language accepted by your receiving office. If that language is not accepted by your chosen ISA, you must provide a translation in a language the ISA accepts. Publication languages for the PCT are Arabic, Chinese, English, French, German, Japanese, Korean, Portuguese, Russian, and Spanish. Receiving offices must accept at least one language that is both an ISA language and a publication language, so you always have at least one option that avoids translation requirements during the international phase.
ePCT Electronic Filing
WIPO strongly recommends filing through ePCT, its web-based platform for preparing, filing, and managing PCT applications. ePCT validates data as you enter it, flags inconsistencies, monitors deadlines, and provides fee reductions for electronic filing. Most receiving offices accept ePCT filings. Filing electronically also reduces the international filing fee -- a reduction of 100-300 CHF depending on the format used.
Choosing an International Searching Authority (ISA)
The ISA conducts the international search and prepares the written opinion on patentability. Your choice of ISA can significantly affect the quality, cost, and speed of your search results, so this decision deserves careful thought.
Available ISAs
The following patent offices have been appointed as International Searching Authorities: Australia, Austria, Brazil, Canada, Chile, China, Egypt, the Eurasian Patent Office (EAPO), the European Patent Office (EPO), Finland, India, Israel, Japan, the Nordic Patent Institute (NPI), the Philippines, the Republic of Korea (KIPO), the Russian Federation, Singapore, Spain, Sweden, Turkey, Ukraine, the United States (USPTO), and the Visegrad Patent Institute (VPI).
Not all ISAs are available to all applicants. Your receiving office determines which ISAs are competent for your application. Some receiving offices give you a choice between multiple ISAs; others designate only one.
Comparison of Major ISAs
| ISA | Search Fee (approx. CHF) | Strengths | Typical Timeline | Languages Accepted |
|---|---|---|---|---|
| EPO | ~1,775 | Highest quality, comprehensive; widely respected by national offices | 4-6 months | English, French, German |
| USPTO | ~2,080 | Strong in software, biotech, pharma; useful for U.S.-focused prosecution | 3-5 months | English |
| JPO | ~1,100 | Strong in electronics, mechanical; lower cost than EPO/USPTO | 4-6 months | English, Japanese |
| KIPO | ~990 | Cost-effective; strong in electronics, telecommunications | 3-5 months | English, Korean |
| CNIPA (China) | ~370 | Lowest cost major ISA; growing search quality | 4-6 months | English, Chinese |
| IP Australia | ~1,200 | Strong in mining, agriculture, biotech; English-language expertise | 3-5 months | English |
Strategic ISA selection. Choose your ISA based on where you plan to prosecute, not just on cost. If you expect to enter the national phase at the EPO, an EPO search report will carry more weight with EPO examiners because they are already familiar with their own institution's standards and methodology. The same logic applies to the USPTO. If cost is paramount and your primary markets are in Asia, KIPO or CNIPA may provide adequate search quality at a fraction of the price.
The International Search Report and Written Opinion
What the ISR Contains
The international search report (ISR) lists prior art documents -- published patents, patent applications, and technical literature -- that may affect the patentability of your invention. Each cited document is classified by its relevance to the claims using standard category codes:
| Category | Meaning | Significance |
|---|---|---|
| X | Particularly relevant: taken alone, the document challenges novelty or inventive step | Most serious citation. A single X-category document can anticipate your claim. |
| Y | Particularly relevant when combined with another Y-category document | Two or more Y documents together may destroy inventive step. |
| A | General state of the art; not particularly relevant | Background reference. Does not directly threaten patentability. |
| P | Published between priority date and filing date | Relevant for novelty only (not inventive step) in most jurisdictions. |
| T | Theory or principle underlying the invention | Helps explain the technical background but rarely threatens claims. |
| E | Earlier application published on or after the international filing date | May be relevant for novelty under national law. |
| L | Document cited for another reason (e.g., to challenge priority claim) | Situational relevance. |
What the Written Opinion Contains
The written opinion is a preliminary, non-binding assessment of whether your claims satisfy three patentability criteria: novelty (Article 33(2) PCT), inventive step (Article 33(3) PCT), and industrial applicability (Article 33(4) PCT). It is structured claim by claim, identifying which citations affect which claims and explaining the examiner's reasoning.
If you do not request Chapter II examination (see below), the written opinion automatically becomes the "International Preliminary Report on Patentability (IPRP) Chapter I" and is transmitted to all designated offices at 30 months from the priority date.
Using the ISR Strategically
The ISR and written opinion arrive approximately 16 months from the priority date -- a full 14 months before the national phase deadline. This is your window to make informed decisions:
- Favorable report (mostly A-category citations). Strong indication of patentability. Proceed to national phase with confidence. Consider using the favorable ISR to request PPH acceleration at national offices.
- Mixed report (some X or Y citations). Analyze the citations carefully. Can the claims be amended to overcome them? Consider filing Article 19 amendments or requesting Chapter II examination to refine your position before national phase.
- Unfavorable report (multiple X citations across all independent claims). Serious obstacle. Consider whether amendments can save the core invention. If not, withdrawing before 18-month publication saves you from creating citable prior art and avoids national phase costs entirely.
Optional Chapter II: International Preliminary Examination (IPRP)
What Chapter II Provides
Chapter II gives you a second bite at the apple. By filing a "demand" for international preliminary examination, you engage an International Preliminary Examining Authority (IPEA) -- typically the same office that conducted the international search -- to conduct a more thorough patentability analysis.
The critical advantage of Chapter II is the opportunity to amend. Under Article 34 of the PCT, you can amend the claims, description, and drawings before the IPEA. You can also submit arguments. The examiner reviews the amended application and issues a new report -- the International Preliminary Report on Patentability (IPRP Chapter II). This report replaces the earlier written opinion as the document transmitted to designated offices.
When to Request Chapter II
Request Chapter II when:
- The written opinion identifies significant issues (X or Y citations) that you believe you can overcome through claim amendments.
- You want to refine your claims before entering national phase, so that designated offices see a stronger application from the start.
- You want to engage in a dialogue with the examiner -- Chapter II allows informal communication and interviews that are not available in Chapter I.
Do not request Chapter II when:
- The written opinion is already favorable (no X or Y citations). The additional cost and time add no value.
- The citations are so damaging that no reasonable amendment can save the claims. You are better off withdrawing or redirecting your strategy.
- Cost is a critical constraint. The preliminary examination fee (varying by IPEA, typically 1,500-2,500 CHF) may not be justified.
Chapter II Deadlines and Costs
The demand for Chapter II must be filed by 22 months from the priority date (or 3 months from the ISR transmittal, whichever expires later). The preliminary examination fee varies by IPEA. At the EPO, the fee is approximately 1,930 EUR. At the USPTO, approximately $600 USD. Article 34 amendments must be filed with the demand or within the time limit set by the IPEA.
National Phase Entry
National phase entry is where the PCT timeline converges with reality. You must take concrete action in each country where you want patent protection, and the deadlines are non-negotiable.
The 30/31-Month Deadline
For the vast majority of PCT contracting states, the deadline for entering the national phase is 30 months from the priority date. A small number of offices allow 31 months. This deadline is fatal -- if you miss it, your PCT application loses its effect in that country and there is generally no way to revive it.
Missing the 30-month deadline is the most costly mistake in PCT practice. Unlike many procedural deadlines in patent prosecution, the national phase entry deadline cannot be extended through petitions or requests for continued examination. Some offices provide a very narrow late-entry window under PCT Rule 49.6 (reinstatement of rights), but the availability and requirements vary dramatically by country, and many applicants' requests are denied. Treat 30 months as an absolute, non-extendable deadline.
What National Phase Entry Requires
Each designated office has its own requirements, but the common elements are:
| Requirement | Details |
|---|---|
| Translation | Full translation of the application into the language required by the national office. This is often the largest single cost. |
| National fees | Filing fees, examination fees, and designation fees payable to the national office. Amounts vary widely by country. |
| Local patent agent | Most countries require you to appoint a local patent agent or attorney to act on your behalf. |
| Copy of PCT application | Some offices require you to submit a copy of the international application, though many access it directly from WIPO. |
| Naming the inventor | Some offices have specific inventor declaration requirements beyond what is in the PCT request form. |
| Priority document | Some offices require a certified copy of the priority document or access via WIPO DAS. |
Country-by-Country Overview
| Office | Deadline | Language | Key Requirements | Approximate Entry Cost (Fees Only) |
|---|---|---|---|---|
| USPTO | 30 months | English | Filing fee, oath/declaration, translation if needed | $1,600-2,400 (entity-dependent) |
| EPO | 31 months | English, French, or German | Filing fee, designation fee, claims translation | $2,000-4,000 |
| JPO | 30 months | Japanese | Translation, filing fee, examination request (within 3 years of international filing) | $1,500-3,000 |
| CNIPA (China) | 30 months | Chinese | Full translation, filing fee, substantive examination request | $800-1,500 |
| KIPO (South Korea) | 31 months | Korean | Translation, filing fee | $800-1,200 |
| IP India | 31 months | English or Hindi | Filing fee, examination request | $400-800 |
| IP Australia | 31 months | English | Filing fee, examination request (within 5 years) | $700-1,200 |
Translation costs dominate the national phase budget. For a typical 30-page patent application, professional translation into Japanese, Chinese, or Korean can cost $5,000-10,000 per language. For a five-country portfolio, translation alone can exceed $30,000. This is why the PCT's 30-month window is so valuable -- it lets you defer these costs until you have better information about your invention's commercial potential.
PCT Fees
International Phase Fees
Three fees are payable when you file a PCT application. All are paid to the receiving office.
| Fee Type | Amount (2024) | Notes |
|---|---|---|
| International filing fee | 1,330 CHF (base) | Surcharge of 15 CHF per page over 30 pages. Reductions of 100-300 CHF for electronic filing. |
| Search fee | Varies by ISA (370-2,080 CHF) | Paid to the receiving office, which transmits it to the ISA. See ISA comparison table above. |
| Transmittal fee | Varies by receiving office (50-300 CHF equivalent) | The receiving office's fee for processing and transmitting the application. |
Fee Reductions
Electronic filing reductions. Filing via ePCT in XML format reduces the international filing fee by 300 CHF. Filing in PDF format via ePCT reduces it by 100 CHF.
Developing country reductions. Natural persons who are nationals of and reside in qualifying developing countries are entitled to a 90% reduction in the international filing fee and certain other fees. This same reduction applies to any person (natural or legal) from a UN-designated least developed country. If there are multiple applicants, each must qualify.
ISA-specific reductions. Some ISAs offer reduced search fees for applicants from certain countries. The EPO, for example, offers a 75% reduction in search and examination fees for applicants from qualifying states.
PCT International Search Fee by ISA (approx. CHF, 2024)
Total International Phase Cost Estimate
For a typical PCT application filed electronically with an EPO search:
| Component | Amount |
|---|---|
| International filing fee (electronic XML) | 1,030 CHF |
| EPO search fee | 1,775 CHF |
| Transmittal fee (typical) | ~150 CHF |
| Total international phase |
With CNIPA as ISA, the total drops to approximately 1,550 CHF (~$1,800 USD). These figures do not include patent attorney fees for preparing the application, which are a separate cost.
Common PCT Mistakes
1. Missing the 30-Month National Phase Deadline
This is the single most damaging error in PCT practice. Unlike most patent deadlines, the national phase entry deadline is not extendable at most offices. A handful of offices provide reinstatement under PCT Rule 49.6, but the requirements are strict -- typically requiring proof that the failure was "unintentional" or occurred "in spite of due care" -- and many requests are denied. Calendar the 30-month deadline the moment you file and set multiple reminders.
2. Choosing the Wrong ISA
Selecting an ISA based solely on cost can backfire. A low-cost search that misses critical prior art provides false confidence and exposes you to surprises during national phase examination. Conversely, an expensive search that aligns with your primary target office gives examiners in that office a search they trust, potentially reducing office actions and prosecution time.
3. Failing to Amend Claims After the ISR
The ISR and written opinion are a free consultation from an expert examiner. Ignoring negative findings and entering national phase with the same claims is a missed opportunity. Article 19 amendments (claims only, filed with WIPO) and Article 34 amendments (claims, description, and drawings, filed during Chapter II) let you address problems before national examiners see your application.
4. Not Using ePCT
Paper filing incurs higher fees, lacks automatic data validation, and makes deadline management more difficult. ePCT provides real-time access to your application file, fee payment integration, deadline alerts, and communication tracking. There is no practical advantage to paper filing.
5. Filing the PCT Application After the 12-Month Priority Window
If you miss the 12-month window from your earliest priority filing, you lose the ability to claim that priority date. Your PCT application's effective date becomes its own filing date, and any intervening publications or filings -- including your own published priority application -- become prior art against your PCT claims.
Patent Prosecution Highway (PPH) and PCT Work Products
The PCT-Patent Prosecution Highway allows you to use favorable PCT work products (the ISR written opinion or the IPRP Chapter II report) to request accelerated examination at national offices. If the PCT examiner found at least one claim to be novel, involve an inventive step, and have industrial applicability, you can file a PPH request at a participating national office.
Using the PCT-PPH to accelerate national phase examination based on favorable PCT work products.
PPH is available at most major offices including the USPTO, EPO, JPO, KIPO, CNIPA, IP Australia, and many others. The request is free at most offices. Grant rates for PPH applications are significantly higher than for standard applications -- not because the standard is lower, but because applicants have already refined their claims through one round of international examination.
To use PCT-PPH, your national phase claims must "sufficiently correspond" to the claims found patentable in the PCT work product. You submit copies of the PCT search report, written opinion, and any translations along with a claim correspondence table showing how each national phase claim maps to an allowable PCT claim.
Strategic Considerations
When to File the PCT Application
Most applicants file the PCT application at the end of the 12-month Paris Convention priority period -- that is, 12 months after their initial national filing. This maximizes the total time before national phase entry (30 months from the priority date, which is 18 months after the PCT filing).
However, filing earlier has advantages. Filing the PCT application immediately after (or simultaneously with) the initial national application gives you the ISR sooner, which in turn gives you more time to make strategic decisions before national phase.
Selective National Phase Entry
You are not required to enter the national phase in all 158 contracting states. You choose which countries to pursue based on market analysis, competitive landscape, budget, and the ISR results. This flexibility is the PCT's greatest strategic advantage. An applicant who initially contemplated filing in 10 countries can reduce to 3 after receiving an unfavorable ISR, or expand to 15 after receiving a favorable one -- all without having committed to national phase costs in any of them.
Withdrawing Before Publication
If the ISR reveals devastating prior art and you decide not to proceed, withdrawing your PCT application before the 18-month publication date prevents the application from becoming published prior art. This preserves the option to refile (with a new priority date) if you can develop the invention further. Once the application is published on PATENTSCOPE, it becomes part of the public record permanently.
Frequently Asked Questions
PCT Basics
Filing and Process
National Phase and Costs
What's Next
This chapter covered the PCT system as a unified international filing mechanism. Chapter 14 examines the European Patent system in detail -- the EPO examination procedure, the Unitary Patent, opposition proceedings, and how to transition from a PCT application into European patent prosecution.